Patents by Inventor Yoon Suk Lee

Yoon Suk Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240262799
    Abstract: Disclosed are methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, disorder of bile acid homeostasis, or organ fibrosis, which includes administering to a subject a therapeutically effective amount of a pharmaceutical composition containing an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.
    Type: Application
    Filed: January 23, 2024
    Publication date: August 8, 2024
    Applicant: IL DONG PHARMACEUTICAL CO., LTD.
    Inventors: Jae-Hoon KANG, Hong-Sub LEE, Yoon-Suk LEE, Jin-Ah JEONG, Sung-Wook KWON, Jeong-Guen KIM, Kyung-Sun KIM, Dong-Keun SONG, Sun-Young PARK, Kyeo-Jin KIM, Ji-Hye CHOI, Hey-Min HWANG
  • Publication number: 20240246961
    Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.
    Type: Application
    Filed: January 23, 2024
    Publication date: July 25, 2024
    Inventors: Sung-Ku CHOI, Yoon-Suk LEE, Sung-Wook KWON, Kyung-Sun KIM, Jeong-Geun KIM, Jeong-Ah KIM, An-Na MOON, Sun-Young PARK, Jun-Su BAN, Dong-Keun SONG, Kyu-Sic JANG, Ju-Young JUNG, Soo-Jin LEE
  • Patent number: 12039297
    Abstract: A code inspection interface providing method according to an embodiment of this disclosure includes providing a graphical user interface (GUI) for performing code inspection, executing an analysis routine on an inspection target code when the inspection target code is selected through the GUI, and providing the result of executing the analysis routine. The analysis routine may include an operation of extracting an abstract syntax tree includes a plurality of nodes from the inspection target code. A code inspection interface providing method is capable of providing an interface that can analyze a code and detect a security vulnerability in real time regardless of the language version of the code and an apparatus for implementing the method.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: July 16, 2024
    Assignee: SAMSUNG SDS CO., LTD.
    Inventors: Hyung Suk Moon, Hee Cheol Park, Yoon Chan Jhi, Jong Hwan Lee
  • Patent number: 11970493
    Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.
    Type: Grant
    Filed: October 4, 2021
    Date of Patent: April 30, 2024
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Sung-Ku Choi, Yoon-Suk Lee, Sung-Wook Kwon, Kyung-Sun Kim, Jeong-Geun Kim, Jeong-Ah Kim, An-Na Moon, Sun-Young Park, Jun-Su Ban, Dong-Keun Song, Kyu-Sic Jang, Ju-Young Jung, Soo-Jin Lee
  • Publication number: 20240067524
    Abstract: Sustainable upcycling method of preparing an electrocatalyst, the method including: providing an electrode material obtained from a lithium-ion battery, wherein the electrode material includes LiFePO4@N-doped carbon core-shell particles; contacting the electrode material with an aqueous solution comprising an acid thereby forming the electrocatalyst; and optionally drying the electrocatalyst.
    Type: Application
    Filed: August 25, 2023
    Publication date: February 29, 2024
    Inventors: Lawrence Yoon Suk LEE, Mengjie LIU
  • Patent number: 11912674
    Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: February 27, 2024
    Assignee: IL DONG PHARMACEUTICAL CO., LTD.
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Yoon-Suk Lee, Jin-Ah Jeong, Sung-Wook Kwon, Jeong-Guen Kim, Kyung-Sun Kim, Dong-Keun Song, Sun-Young Park, Kyeo-Jin Kim, Ji-Hye Choi, Hey-Min Hwang
  • Publication number: 20240041888
    Abstract: Adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds are disclosed. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson's disease. The compounds and compositions may also find use in various therapeutic applications including the treatment of cancer and in immuno-oncology.
    Type: Application
    Filed: October 2, 2023
    Publication date: February 8, 2024
    Applicant: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Kyung-Sun KIM, Jeong-Ah KIM, An-Na MOON, DONG-Keun SONG, Yoon-Suk LEE, Ju-Young JUNG
  • Patent number: 11806350
    Abstract: Adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds are disclosed. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson's disease. The compounds and compositions may also find use in various therapeutic applications including the treatment of cancer and in immuno-oncology.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: November 7, 2023
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Kyung-Sun Kim, Jeong-Ah Kim, An-Na Moon, Dong-Keun Song, Yoon-Suk Lee, Ju-Young Jung
  • Publication number: 20230159534
    Abstract: The present disclosure provides adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of cancer and in immuno-oncology. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson’s disease.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 25, 2023
    Applicant: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Yoon-Suk LEE, Sung-Wook KWON, Kyung-Sun KIM, Jeong-Geun KIM, Jeong-Ah KIM, An-Na MOON, Sun-Young PARK, Jun-Su BAN, Dong-Keun SONG, Ju-Young JUNG, Soo-Jin LEE
  • Publication number: 20220380376
    Abstract: The present disclosure provides phosphodiesterase 5 (PDE-5) and/or phosphodiesterase 6 (PDE-6) inhibitor compounds and compositions including said compounds. In some embodiments, said compounds are nitrogen oxide (NO) donating PDE-5 and/or -6 inhibitor compounds that include a nitrogen oxide-containing donor substituent attached to a benzenesulfonamide group. The compounds can provide dual functionality for increasing protein kinase G (PKG) activity by inhibiting PDE-5 and PDE-6, and/or stimulating guanylate cyclase (sGC) via donation of nitrogen oxide (NO) from the donor substituent of the compound. The present disclosure also provides methods of using said compounds and compositions for inhibiting PDE-5 and/or -6 and increasing activity of protein kinase G (PKG). The compounds and compositions find use in therapeutic applications including in the treatment of a variety of eye diseases.
    Type: Application
    Filed: May 10, 2022
    Publication date: December 1, 2022
    Inventors: Yoon-Suk LEE, Sung-Wook KWON, Kyung-Sun KIM, Jeong-Geun KIM, Jeong-Ah KIM, An-Na MOON, Sun-Young PARK, Jun-Su BAN, Dong-Keun SONG, Ju-Young JUNG, Soo-Jin LEE
  • Publication number: 20220152034
    Abstract: Adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds are disclosed. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson's disease. The compounds and compositions may also find use in various therapeutic applications including the treatment of cancer and in immuno-oncology.
    Type: Application
    Filed: November 17, 2021
    Publication date: May 19, 2022
    Applicant: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Kyung-Sun KIM, Jeong-Ah KIM, An-Na MOON, Dong-Keun SONG, Yoon-Suk LEE, Ju-Young JUNG
  • Publication number: 20220153746
    Abstract: The present disclosure provides uses of phosphodiesterase 5 (PDE-5) and/or phosphodiesterase 6 (PDE-6) inhibitor compounds and uses of compositions including said compounds. In some embodiments, said compounds are nitrogen oxide (NO) donating PDE-5 and/or -6 inhibitor compounds that include a nitrogen oxide-containing donor substituent attached to a benzenesulfonamide group. The compounds can provide dual functionality for increasing protein kinase G (PKG) activity by inhibiting PDE-5 and PDE-6, and/or stimulating guanylate cyclase via donation of NO from the donor substituent of the compound. The present disclosure also provides methods of using said compounds and compositions for inhibiting PDE-5 and/or -6 and increasing activity of PKG. The compounds and compositions find use in the treatment of a variety of eye diseases.
    Type: Application
    Filed: November 8, 2021
    Publication date: May 19, 2022
    Inventors: Yoon-Suk LEE, Kyung-Sun KIM, Jeong-Ah KIM, An-Na MOON, Dong-Keun SONG, Ju-Young JUNG
  • Publication number: 20220106311
    Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.
    Type: Application
    Filed: October 4, 2021
    Publication date: April 7, 2022
    Inventors: Sung-Ku Choi, Yoon-Suk Lee, Sung-Wook Kwon, Kyung-Sun Kim, Jeong-Geun Kim, Jeong-Ah Kim, An-Na Moon, Sun-Young Park, Jun-Su Ban, Dong-Keun Song, Kyu-Sic Jang, Ju-Young Jung, Soo-Jin Lee
  • Publication number: 20210188790
    Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.
    Type: Application
    Filed: March 4, 2021
    Publication date: June 24, 2021
    Inventors: Jae-Hoon KANG, Hong-Sub Lee, Yoon-Suk Lee, Jin-Ah Jeong, Sung-Wook Kwon, Jeong-Guen Kim, Kyung-Sun Kim, Dong-Keun Song, Sun-Young Park, Kyeo-Jin Kim, Ji-Hye Choi, Hey-Min Hwang
  • Patent number: 10988449
    Abstract: The present invention relates to isoxazole derivatives, including pharmaceutical compositions and for the preparation of isoxazole derivatives. And more particularly the present invention provided a pharmaceutical composition of isoxazole derivatives for activation of Farnesoid X receptor (FXR, NR1H4).
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: April 27, 2021
    Assignee: IL DONG Pharmaceutical Co., Ltd.
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Yoon-Suk Lee, Jin-Ah Jeong, Sung-Wook Kwon, Jeong-Guen Kim, Kyung-Sun Kim, Dong-Keun Song, Sun-Young Park, Kyeo-Jin Kim, Ji-Hye Choi, Hey-Min Hwang
  • Patent number: 10636167
    Abstract: A method and device for determining a distance are provided. The method includes determining a first binocular distance between two eyes of a user by using a first image captured through a camera of the device, determining a second binocular distance between the two eyes of the user by using a second image captured through the camera, determining a distance from the camera to the two eyes of the user based on the first binocular distance and the second binocular distance, and providing an image to a display of the device, the image converted according to the distance from the camera to the two eyes of the user.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: April 28, 2020
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Seok-myong Kang, Yoon-suk Lee, Jong-woo Lee, Jong-gu Jeon
  • Publication number: 20200115349
    Abstract: The present invention relates to isoxazole derivatives, including pharmaceutical compositions and for the preparation of isoxazole derivatives. And more particularly the present invention provided a pharmaceutical composition of isoxazole derivatives for activation of Farnesoid X receptor (FXR, NR1H4).
    Type: Application
    Filed: April 12, 2018
    Publication date: April 16, 2020
    Inventors: Jae-Hoon KANG, Hong-Sub LEE, Yoon-Suk LEE, Jin-Ah JEONG, Sung-Wook KWON, Jeong-Guen KIM, Kyung-Sun KIM, Dong-Keun SONG, Sun-Young PARK, Kyeo-Jin KIM, Ji-Hye CHOI, Hey-Min HWANG
  • Patent number: 10302256
    Abstract: A lighting apparatus including a plurality of frames connected to each other in the lengthwise direction; a connector, which is arranged between the plurality of frames and interconnects the plurality of frames by including a portion inserted into one of the plurality of frames, and including another portion inserted into the other one of the plurality of frames; and a light source arranged on the plurality of frames.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: May 28, 2019
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Young-kwang Kwon, Joo-hun Han, Bang-won Oh, Du-su Kwon, Hyun-kyung Kim, Yoon-ki Park, Yoon-suk Lee
  • Publication number: 20180137648
    Abstract: A method and device for determining a distance are provided. The method includes determining a first binocular distance between two eyes of a user by using a first image captured through a camera of the device, determining a second binocular distance between the two eyes of the user by using a second image captured through the camera, determining a distance from the camera to the two eyes of the user based on the first binocular distance and the second binocular distance, and providing an image to a display of the device, the image converted according to the distance from the camera to the two eyes of the user.
    Type: Application
    Filed: August 9, 2017
    Publication date: May 17, 2018
    Inventors: Seok-myong KANG, Yoon-suk LEE, Jong-woo LEE, Jong-gu JEON
  • Patent number: RE49338
    Abstract: The present invention relates to phthalazinone derivatives, including pharmaceutical compositions and for the preparation of phthalazinone derivatives. And more particularly the present invention provided a pharmaceutical composition of phthalazinone derivatives for inhibiting activity of the Poly(ADP-riboside) polymerase enzyme.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: December 20, 2022
    Assignee: IDIENCE CO., LTD.
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Yoon-Suk Lee, Joon-Tae Park, Kyung-Mi An, Jin-Ah Jeong, Kyung-Sun Kim, Jeong-Geun Kim, Chang-Hee Hong, Sun-Young Park, Dong-Keun Song, Yong-Don Yun